Immunotherapy is one of the four major therapies for cancer
Immune cells are the police system in the human body. They are responsible for removing cells that are infected by bacteria or abnormal in the body, but tumor cells will pretend to be normal cells, inhibit the activity of immune cells, and even manipulate immune cells. Therefore, when the immune system is not strong enough, Tumor cells will accumulate in our body.
In current cancer treatment methods, surgery will induce tumor cells to escape, and chemotherapy and radiotherapy will weaken the patient’s already weak immune system. Cancer patients often face the risk of cancer metastasis or recurrence.
In 2000, the International Annual Conference on Cancer Biotherapy and Gene Therapy pointed out that immune cell therapy is the only method in science and technology that can completely eliminate cancer cells. A complete immune system is the key to completely eliminating cancer cells.
Regulations Governing the Application of Specific Medical Technique and Medical Device has opened autoimmune cell therapy
Although standard therapies such as medicine, surgery, and radiation can treat many diseases, the therapeutic effects vary from person to person. Therefore, for terminal cancer, degenerative diseases, and chronic diseases, they may still be helpless, unable to cure, or have poor therapeutic effects. A
Autoimmune cell therapy is an auxiliary method to fight cancer. Taiwan announced the “Regulations Governing the Application of Specific Medical Technique and Medical Device” in September 2018 and opened 6 autoimmune cell therapy projects. It is hoped that it can provide more patients with limited traditional treatment. A medical option also increases the chance of recovery, but it does not mean that it can replace the traditional standard treatment. A
Cancer treatment of autoimmune cells is classified as a self-funded program and is currently only open to cancer patients who meet the following qualifications:
Hematological malignancies, which are not effective after standard treatment
Solid tumor of the fourth stage
Solid tumors of the first to third stages, who are not effective after standard treatment
It is still the greatest way to store immune cells as soon as possible
As everyone knows, aging and external environmental pollution can damage the quality of immune cells; taking age as an example, immunity will continue to decline with age. Therefore, storing immune cells while young is definitely The best strategy.
When tumors form in the body, the anti-cancer mechanism representing the immune system has failed, including a decrease in the number of dendritic cells, a decrease in the number of lymphocytes, and suppression of immune cell activity. If you plan to collect immune cells after you have cancer, the cancer has a high probability that you will not be able to obtain enough immune cells for cultivation, immune cell proliferation is difficult, or the cell’s anti-cancer activity is low. A
Therefore, storing healthy immune cells early is still the most important key to immune cell therapy.
Entrust a cell processing laboratory that complies with GTP specifications to help you store immune cells
Viesaine International Health Consult commissioned a high-end cell processing laboratory that complies with GTP specifications to launch an immune cell storage solution to store a copy of health and hope for each customer.
High-quality immune storage solution collects more than 1.5 billion immune cells for you through a blood cell separator, which can be used in DC vaccine, NK cell therapy and LAK cell therapy in the future.
VIP immune cell storage program: 180 million immune cells are collected from 250 c.c. whole blood, which can be used in NK cell therapy and LAK cell therapy in the future.